Ads
related to: donor portal grifolslearn.bonterratech.com has been visited by 10K+ users in the past month
Search results
Results from the Go Local Guru Content Network
Grifols, S.A. ( Catalan: [ˈɡɾifuls]) is a Spanish multinational pharmaceutical and chemical manufacturer. Principally a producer of blood plasma –based products, a field in which it is the European leader and largest worldwide, [3] [4] the company also supplies devices, instruments, and reagents for clinical testing laboratories .
Grifols-Lucas concluded that it was possible for donors to undergo plasmapheresis on a weekly basis without the quality of their plasma suffering, while the method also made it possible to obtain a larger quantity of plasma when compared to the conventional method of whole blood donation.
Dr. Grifols pioneered a first-of-its-kind technique called plasmapheresis, where a donor's red blood cells would be returned to the donor's body almost immediately after the separation of the blood plasma. This technique is still in practice today, almost 80 years later. In 1945, Dr. Grifols opened the world's first plasma donation center.
Grifols said it managed to cut the cost of collecting plasma by 22% as of September 2023 from its peak in July 2022 as the company reduced structural costs and the payments it makes to blood...
Short-seller fund Gotham City Research on Tuesday issued a second report on Grifols, maintaining some of its questions over the Spanish pharmaceutical company's accounting practices.
The National Donor Deferral Registry, also known as the (NDDR) is a database of individuals who have tested "reactive" for viral agents like human immunodeficiency viruses (HIV), Hepatitis B virus (HBV), and hepatitis C virus (HCV) and are permanently prohibited from donating plasma. [1]
Ad
related to: donor portal grifolsinfo.biolifeplasma.com has been visited by 10K+ users in the past month